These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31618791)

  • 1. Is TNF inhibitor exposure a risk factor for amyotrophic lateral sclerosis?
    Bougea A
    Fundam Clin Pharmacol; 2019 Dec; 33(6):687-688. PubMed ID: 31618791
    [No Abstract]   [Full Text] [Related]  

  • 2. Is TNF inhibitor exposure a risk factor for amyotrophic lateral sclerosis?
    Petitpain N; Devos D; Bagheri H; Rocher F; Gouraud A; Masmoudi K; Coquerel A
    Fundam Clin Pharmacol; 2019 Dec; 33(6):689-694. PubMed ID: 31058354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No association between rheumatoid arthritis, amyotrophic lateral sclerosis, and tumour necrosis factor inhibitor treatment.
    Arkema EV; Feltelius N; Olsson T; Askling J;
    Ann Rheum Dis; 2014 Nov; 73(11):2061-2. PubMed ID: 25096786
    [No Abstract]   [Full Text] [Related]  

  • 4. Antecedent events in amyotrophic lateral sclerosis.
    Felmus MT; Patten BM; Swanke L
    Neurology; 1976 Feb; 26(2):167-72. PubMed ID: 946326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyotrophic lateral sclerosis in a high selenium environment.
    Kilness AW; Hichberg FH
    JAMA; 1977 Jun; 237(26):2843-4. PubMed ID: 577250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Amyotrophic lateral sclerosis after years of lead exposure?].
    Woitowitz HJ; Rösler J
    Dtsch Med Wochenschr; 1995 Mar; 120(12):424. PubMed ID: 7705206
    [No Abstract]   [Full Text] [Related]  

  • 7. A meta-analysis of observational studies of the association between chronic occupational exposure to lead and amyotrophic lateral sclerosis.
    Wang MD; Gomes J; Cashman NR; Little J; Krewski D
    J Occup Environ Med; 2014 Dec; 56(12):1235-42. PubMed ID: 25479292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyotrophic lateral sclerosis and metallic toxins.
    Currier RD; Haerer AF
    Arch Environ Health; 1968 Nov; 17(5):712-9. PubMed ID: 4879837
    [No Abstract]   [Full Text] [Related]  

  • 9. Amyotrophic lateral sclerosis and occupational heavy metal exposure: a case-control study.
    Gresham LS; Molgaard CA; Golbeck AL; Smith R
    Neuroepidemiology; 1986; 5(1):29-38. PubMed ID: 3748267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenesis of amyotrophic lateral sclerosis.
    Yase Y
    Lancet; 1972 Aug; 2(7772):292-6. PubMed ID: 4115029
    [No Abstract]   [Full Text] [Related]  

  • 11. Amyotrophic lateral sclerosis and toxic hydrocarbons.
    Hudson AJ
    Arch Neurol; 1977 Nov; 34(11):721. PubMed ID: 911240
    [No Abstract]   [Full Text] [Related]  

  • 12. Amyotrophic lateral sclerosis and selenium.
    JAMA; 1977 Nov; 238(22):2365-6. PubMed ID: 578856
    [No Abstract]   [Full Text] [Related]  

  • 13. Amyotrophic lateral sclerosis and occupational exposure to 2,4-dichlorophenoxyacetic acid.
    Freedman M
    Occup Environ Med; 2001 Sep; 58(9):609-10. PubMed ID: 11529236
    [No Abstract]   [Full Text] [Related]  

  • 14. A Comparison of Mercury Exposure from Seafood Consumption and Dental Amalgam Fillings in People with and without Amyotrophic Lateral Sclerosis (ALS): An International Online Case-Control Study.
    Parkin Kullmann JA; Pamphlett R
    Int J Environ Res Public Health; 2018 Dec; 15(12):. PubMed ID: 30558238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins and amyotrophic lateral sclerosis--the level of evidence for an association.
    Sørensen HT; Lash TL
    J Intern Med; 2009 Dec; 266(6):520-6. PubMed ID: 19930099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pesticide exposure assessed through agricultural crop proximity and risk of amyotrophic lateral sclerosis.
    Vinceti M; Filippini T; Violi F; Rothman KJ; Costanzini S; Malagoli C; Wise LA; Odone A; Signorelli C; Iacuzio L; Arcolin E; Mandrioli J; Fini N; Patti F; Lo Fermo S; Pietrini V; Teggi S; Ghermandi G; Scillieri R; Ledda C; Mauceri C; Sciacca S; Fiore M; Ferrante M
    Environ Health; 2017 Aug; 16(1):91. PubMed ID: 28851431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour necrosis factor-alpha inhibitor induced recurrent symptomatic hypoglycaemia.
    Mah JY; Teng J; Gilfillan C
    Intern Med J; 2019 Nov; 49(11):1460-1461. PubMed ID: 31713334
    [No Abstract]   [Full Text] [Related]  

  • 18. Understanding the Cause of Weight Gain in Patients With IBD on Anti-TNF Medications.
    Winter RW; Friedman S
    Inflamm Bowel Dis; 2020 Jan; 26(1):132-133. PubMed ID: 31265724
    [No Abstract]   [Full Text] [Related]  

  • 19. An immunohistochemical study of increased tumor necrosis factor-α in the skin of patients with amyotrophic lateral sclerosis.
    Fukazawa H; Tsukie T; Higashida K; Fujikura M; Ono S
    J Clin Neurosci; 2013 Oct; 20(10):1371-6. PubMed ID: 23850047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lichen planus as paradoxical side effect of TNF-α inhibitors treatment in one patient with many psoriasis comorbidities.
    Veronese F; Graziola F; Savoia P; Tiberio R
    G Ital Dermatol Venereol; 2019 Aug; 154(4):501-502. PubMed ID: 29249123
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.